Form 4: Innovex International CFO Kyle McClure Reports Share Transactions Following Merger
SEC Form 4 Filing
Kyle McClure, Vice President and CFO of Innovex International, reports the acquisition and disposal of common stock related to the vesting and settlement of performance units and restricted stock awards following the company's merger.
Summary
- On September 6, 2024, Kyle McClure, Vice President and CFO of Innovex International, acquired 81,189 shares of common stock upon the vesting and settlement of performance unit awards related to the company's merger.
- He also acquired 148,194 shares of common stock.
- McClure disposed of 31,950 shares at $15.41 to cover tax withholding obligations related to the performance units.
- Additionally, he disposed of 21,802 shares at $15.41 to cover tax withholding obligations related to restricted stock awards.
- Following these transactions, McClure beneficially owns 94,442 shares of Innovex International common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and tax obligations following a merger. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive compensation and ownership changes.
Stakeholder Impact
- Shareholders can monitor insider transactions to understand executive compensation and alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| March 18, 2024 | Date of the original Agreement and Plan of Merger among Innovex International, its subsidiaries, and Innovex Downhole Solutions, Inc. |
| June 12, 2024 | Date of the First Amendment to the Agreement and Plan of Merger. |
| September 6, 2024 | Date of the earliest transaction reported, including vesting of performance units and restricted stock, and tax-related disposals; also the date of McClure's Separation Agreement. |
| September 10, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.